Iman Abou Dalle

Statistics

Publications

Citations

197

H-Index

Active since

2018

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

American University of Beirut Medical Center

Iman Abou Dalle is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, hematologic malignancy therapy, and acute myeloid leukemia therapy.

ORCID

Publications per year

2018–2023

Publications

Successful lenalidomide treatment in high risk myelodysplastic syndrome with germline <i>DDX41</i> mutation

Iman Abou Dalle, Hagop M. Kantarjian, Sarah A. Bannon et al. · American Journal of Hematology · 2019 · 41 citations · Full text

Medicine, Genetics, Oncology +17

Efficacy and safety of generic imatinib after switching from original imatinib in patients treated for chronic myeloid leukemia in the United States

Iman Abou Dalle, Hagop M. Kantarjian, Jan A. Burger et al. · Cancer Medicine · 2019 · 35 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +7

Prognostic significance of baseline <i>FLT3</i>‐ITD mutant allele level in acute myeloid leukemia treated with intensive chemotherapy with/without sorafenib

Fevzi Yalniz, Iman Abou Dalle, Hagop M. Kantarjian et al. · American Journal of Hematology · 2019 · 34 citations · Full text

Medicine, Hematology, Oncology +14

Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid leukemia

Iman Abou Dalle, Ahmad Ghorab, Keyur P. Patel et al. · Blood Cancer Journal · 2020 · 33 citations · Full text

Medicine, Oncology, Pharmacology +14

A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia

Iman Abou Dalle, Jörge E. Cortes, Pramod Pinnamaneni et al. · Acta Haematologica · 2018 · 18 citations · Full text

Medicine, Oncology, Pharmacology +15

1–5 of 8